4.3 NO-releasing agents in overcoming tumor hypoxia Tumor hypoxia, a hallmark of solid malignancies such as CRC, drives therapeutic resistance, immunosuppression, and metastasis
Home use: Apply 35 drops twice daily to clean, damp skin

SHINE AND GLOW: Infused with Vitamin C, Niacinamide (Vitamin B3 and Nicotinamide) ALLEVIATE FOR SENSITIVE SKIN: Solanum Melongena (Eggplant) extract WATER, GLYCERIN, STEARIC ACID, CENTELLA ASIATICA EXTRACT, LAURIC ACID, POTASSIUM HYDROXIDE, MYRISTIC ACID, 1,2-HEXANEDIOL, GLYCOL DISTEARATE, COCO-GLUCOSIDE, POTASSIUM COCOYL GLYCINATE, SORBITAN OLIVATE, GLUTATHIONE, BEESWAX, NIACINAMIDE, GLYCERYL STEARATE, PEG-100 STEARATE, POLYSORBATE 60, NELUMBO NUCIFERA EXTRACT, ARTEMISIA ANNUA EXTRACT, ORYZA SATIVA (RICE) EXTRACT, SACCHAROMYCES FERMENT, BUTYLENE GLYCOL, SOLANUM MELONGENA (EGGPLANT) FRUIT EXTRACT, MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF EXTRACT, HYDROLYZED COLLAGEN, BETA-GLUCAN, HIPPOPHAE RHAMNOIDES FRUIT EXTRACT, DIPROPYLENE GLYCOL, HYDROXYPROPYL METHYLCELLULOSE, MADECASSIC ACID, ASIATICOSIDE, ASIATIC ACID, SQUALANE, SODIUM HYALURONATE, DISODIUM EDTA, CAPRYLIC/CAPRIC TRIGLYCERIDE, HYDROGENATED LECITHIN, CHOLESTEROL, XANTHAN GUM *** Ingredients are subject to change at the manufacturer's discretion

A recent study has demonstrated that an acute increase in the intracellular concentration of ROS inhibits the glycolytic enzyme pyruvate kinase M2 (PKM2) through the oxidation of Cys358 ( NRF2 INHIBITORS FOR ANTICANCER THERAPY Due to the multifaceted roles of Nrf2 in cancers, Nrf2 inhibitors could be effective for anticancer therapy